Download presentation
Presentation is loading. Please wait.
1
Evolution of Virulence Matthew H. Bonds The François-Xavier Bagnoud Center for Health and Human Rights Harvard School of Public Health Partners in Health
2
Outline of Presentation 1.Background to Disease Evolution - Evolution of virulence - Antibiotic resistance - Disease emergence 2.Evolutionary Stable Strategies (ESS) 3.Evolution of Virulence - single infection - multiple infections
3
Background to Disease Evolution 1.Evolution of Virulence 2.Antibiotic Resistance 3.Disease Emergence
4
Background to Disease Evolution 1.Evolution of Virulence 2.Antibiotic Resistance 3.Disease Emergence
5
Background to Disease Evolution 1.Evolution: A change in genetic material in a population from generation to the next. - We say that organisms evolve to “maximize their fitness”
6
Background to Disease Evolution 1.Evolution: A change in genetic material in a population from generation to the next. - We say that organisms evolve to “maximize their fitness” 2. Fitness ≅ Reproductivity
7
Background to Disease Evolution 1.Evolution: A change in genetic material in a population from generation to the next. - We say that organisms evolve to “maximize their fitness” 2. Fitness ≅ Reproductivity = number of surviving offspring or number of reproductive offspring
8
Background to Disease Evolution 1.Evolution: A change in genetic material in a population from generation to the next. - We say that organisms evolve to “maximize their fitness” 2. Fitness ≅ Reproductivity = number of surviving offspring or number of reproductive offspring
9
Evolutionarily Stable Strategy Evolutionarily Stable Strategy (ESS): A strategy which, if adopted by a population, cannot be invaded by any alternative strategy that is initially rare. An ESS is a kind of Nash equilibrium.
10
What is the ESS for a Pathogen?
11
A strategy adopted by some kind of pathogen, for which an alternative (mutant) strategy, cannot invade.
12
What is the ESS for a Pathogen? A strategy adopted by some kind of pathogen, for which an alternative (mutant) strategy, cannot invade.
13
What is the ESS for a Pathogen? A strategy adopted by some kind of pathogen, for which an alternative (mutant) strategy, cannot invade.
14
What is the ESS for a Pathogen? A strategy adopted by some kind of pathogen, for which an alternative (mutant) strategy, cannot invade.
15
What is the ESS for a Pathogen? A strategy adopted by some kind of pathogen, for which an alternative (mutant) strategy, cannot invade.
16
What is the ESS for a Pathogen? A strategy adopted by some kind of pathogen, for which an alternative (mutant) strategy, cannot invade. A strategy that maximizes the Basic Reproductive Ratio is evolutionarily stable (Anderson and May, 1982)
17
ESS for a Pathogen? What are the evolutionary tradeoffs faced by pathogens?
18
ESS for a Pathogen? What are the evolutionary tradeoffs faced by pathogens? Pathogens should evolve to maximize the transmission rate and minimize the disease-induced death rate.
19
ESS for a Pathogen? What are the evolutionary tradeoffs faced by pathogens? Pathogens should evolve to maximize the transmission rate and minimize the disease-induced death rate. There must be a tradeoff between transmission and virulence! ?
20
ESS for a Pathogen?
22
v Tradeoff between transmission and killing the host
23
ESS for a Pathogen? v Maximize Ro with respect to v v*
24
ESS for Multiple Pathogens? v Maximize Ro with respect to v v*
25
ESS for Multiple Pathogens?
28
Maximize Ro with respect to v
29
ESS for Multiple Pathogens?
33
CoESS
34
Summary The evolutionarily stable strategy for a pathogen is the strategy that maximizes its basic reproductive ratio Typically, the phenotype that we consider to be evolving is the disease-induced mortality rate (virulence) There may be a tradeoff between virulence and transmission The ESS level of virulence depends on coinfection. The host represents a common property resource, and the Co-evolutionarily stable strategy is the outcome of a prisoner’s dilemma.
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.